Catalytic investments are a portion of funding for Global Fund-supported programs, activities and strategic investments that are not adequately accommodated through country allocations but that are essential to achieve the aims of the Global Fund Strategy 2017-2022 and global partner plans.
For the 2017-2019 cycle, catalytic investments comprise:
US$800 million in catalytic investments are available in the current 2017-2019 funding cycle.
A number of countries were chosen by the Global Fund to access a predetermined amount of funding. These “matching funds” are designed to inspire innovation and ambitious programming approaches driven by evidence, in order to maximize impact in specific strategic priority areas.
To meet the conditions for matching funds, an applicant would show:
Flexibilities in the implementation of matching funds are possible, where moving funding to meet matching funds requirements would reduce impact or harm programs. Application of flexibilities will be reviewed by the Technical Review Panel and Grant Approvals Committee on a case-by-case basis.
These are the six catalytic investment priority areas designated for the US$313 million matching funds for 2017-2019:
In addition to these priority areas, US$33 million will be made available as matching funds for malaria, to catalyze market entry of new generation long-lasting insecticidal nets.
The Global Fund serves the needs of countries, but diseases don’t respect borders, and sometimes the most effective solution is one that brings together several countries or regions.
Through multicountry funding, the Global Fund aims to address a limited number of key multicountry priorities, deemed critical to fulfill the aims of the Global Fund strategy and not able to be addressed through country allocations alone.
Within each multicountry strategic priority there are specific priority areas for 2017-2019. While several priority areas had pre-identified applicants, there was a competitive application process for the majority of priority areas. Eligible organizations submitted a funding requests to the Global Fund through a competitive application process.
Eleven strategic initiative priority areas were identified as needed to support the success of country allocations, but that cannot be funded through country grants alone. A total of US$194 million is designated for these catalytic investments for 2017-2019:
|Strategic initiative||Objective||Amount (US$ millions)|
|Finding Missing Tuberculosis Cases||Address specific barriers to finding missing tuberculosis cases, develop innovative approaches to accelerate case finding, and scale up tools and approaches.||10|
|Malaria Elimination||Accelerate efforts in 21 countries to achieve the Global Technical Strategy for Malaria to eliminate malaria in at least 35 countries by 2030.||7|
|Catalyzing Market Entry of new Long-lasting Insecticidal Nets||Introduce new technologies in Africa to counter the threat of insecticide resistance (in conjunction with US$33 million matching funds for catalyzing market entry of new long-lasting insecticidal nets.)||2|
|Piloting Introduction of Malaria Vaccine||Contribute to the development of an updated WHO policy recommendation on the use of the RTS,S/AS01 malaria vaccine in young children in sub-Saharan Africa.||15|
|Sustainability, Transition and Efficiency||Accelerate the implementation of Global Fund’s Sustainability, Transition and Co-Financing Policy.||15|
|Resilient and Sustainable Systems for Health: Technical Support, South to South, Peer Review and Learning||Support health systems and effective HIV, tuberculosis and malaria programming.||14|
|Resilient and Sustainable Systems for Health: Data Systems, Generation and Use for Programmatic Action and Quality Improvements||Strengthen health information systems and surveillance; enable country systems to collect, report on and use data; support program impact and thematic evaluations and epidemiological reviews.||20|
|Procurement and Supply Management||Strengthen supply chain through renewed strategic efforts that enhance and promote advances in the supply of medicines to improve universal access.||54|
|Community, Rights and Gender||Build upon progress made in strengthening engagement of civil society and communities most affected by the three diseases in Global Fund processes.||15|
|Prospective Country Evaluations||Document the results of Global Fund-funded programs and share lessons learned.||22|
|Emergency Fund||Support the provision and continuity of essential prevention and treatment services for HIV, tuberculosis and malaria during emergency situations that cannot be funded simply through the reprogramming of existing grants.||20|